Morgan Stanley
FBT icon

Morgan Stanley’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Morgan Stanley’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107M Buy
534,200
+132,999
+33% +$27.5M 0.01% 1380
2025
Q4 		$82.9M Buy
401,201
+61,755
+18% +$12.3M ﹤0.01% 1606
2025
Q3 		$60.9M Sell
339,446
-5,799
-2% -$988K ﹤0.01% 1847
2025
Q2 		$55.7M Sell
345,245
-15,324
-4% -$2.44M ﹤0.01% 1818
2025
Q1 		$61.3M Sell
360,569
-64,018
-15% -$11.1M ﹤0.01% 1631
2024
Q4 		$70.6M Sell
424,587
-6,267
-1% -$1.07M ﹤0.01% 1519
2024
Q3 		$74.1M Buy
430,854
+13,421
+3% +$2.22M 0.01% 1478
2024
Q2 		$64.3M Sell
417,433
-49,891
-11% -$7.49M 0.01% 1512
2024
Q1 		$71.9M Sell
467,324
-938,344
-67% -$143M 0.01% 1429
2023
Q4 		$222M Buy
1,405,668
+758,541
+117% +$109M 0.01% 1086
2023
Q3 		$94.7M Sell
647,127
-198,634
-23% -$30.3M 0.01% 1096
2023
Q2 		$130M Buy
845,761
+69,331
+9% +$10.8M 0.01% 929
2023
Q1 		$120M Buy
776,430
+31,660
+4% +$4.97M 0.01% 959
2022
Q4 		$115M Buy
744,770
+126,555
+20% +$18.7M 0.01% 948
2022
Q3 		$81.6M Sell
618,215
-5,163
-0.8% -$724K 0.01% 1015
2022
Q2 		$84.5M Sell
623,378
-90,741
-13% -$12.5M 0.01% 1036
2022
Q1 		$107M Sell
714,119
-103,199
-13% -$15.3M 0.01% 825
2021
Q4 		$132M Sell
817,318
-26,008
-3% -$4.21M 0.02% 733
2021
Q3 		$140M Sell
843,326
-112,678
-12% -$19.2M 0.02% 663
2021
Q2 		$165M Buy
956,004
+17,344
+2% +$2.86M 0.02% 617
2021
Q1 		$151M Sell
938,660
-63,995
-6% -$11M 0.02% 589
2020
Q4 		$168M Sell
1,002,655
-6,986
-0.7% -$1.13M 0.03% 526
2020
Q3 		$159M Sell
1,009,641
-78,915
-7% -$12.9M 0.03% 450
2020
Q2 		$183M Buy
1,088,556
+253,255
+30% +$39.7M 0.04% 380
2020
Q1 		$110M Buy
835,301
+12,807
+2% +$1.82M 0.03% 469
2019
Q4 		$122M Sell
822,494
-89,182
-10% -$12.2M 0.03% 528
2019
Q3 		$113M Sell
911,676
-600,990
-40% -$80M 0.03% 520
2019
Q2 		$213M Sell
1,512,666
-146,233
-9% -$20.2M 0.06% 330
2019
Q1 		$250M Buy
1,658,899
+104,362
+7% +$15M 0.07% 284
2018
Q4 		$193M Buy
1,554,537
+6,793
+0.4% +$929K 0.06% 327
2018
Q3 		$245M Buy
1,547,744
+574,869
+59% +$87M 0.06% 312
2018
Q2 		$136M Buy
972,875
+51,791
+6% +$7.11M 0.04% 458
2018
Q1 		$122M Buy
921,084
+72,044
+8% +$9.84M 0.03% 493
2017
Q4 		$106M Sell
849,040
-86,852
-9% -$10.7M 0.03% 567
2017
Q3 		$116M Buy
935,892
+47,020
+5% +$5.56M 0.03% 495
2017
Q2 		$101M Buy
888,872
+29,347
+3% +$3.16M 0.03% 555
2017
Q1 		$90.5M Buy
859,525
+51,976
+6% +$5.21M 0.03% 610
2016
Q4 		$73.4M Buy
807,549
+268,093
+50% +$25.1M 0.02% 674
2016
Q3 		$53.8M Buy
539,456
+43,645
+9% +$4.28M 0.02% 808
2016
Q2 		$44.3M Buy
495,811
+11,489
+2% +$1.06M 0.02% 860
2016
Q1 		$42.4M Sell
484,322
-2,326,325
-83% -$205M 0.02% 847
2015
Q4 		$318M Buy
2,810,647
+213,991
+8% +$23M 0.12% 196
2015
Q3 		$263M Sell
2,596,656
-61,180
-2% -$7.28M 0.1% 231
2015
Q2 		$330M Sell
2,657,836
-32,169
-1% -$3.88M 0.11% 201
2015
Q1 		$318M Buy
2,690,005
+237,552
+10% +$26.9M 0.12% 205
2014
Q4 		$250M Buy
2,452,453
+218,997
+10% +$21.4M 0.09% 244
2014
Q3 		$205M Buy
2,233,456
+127,567
+6% +$11.1M 0.08% 281
2014
Q2 		$173M Sell
2,105,889
-138,222
-6% -$10.6M 0.07% 314
2014
Q1 		$172M Buy
2,244,111
+124,136
+6% +$9.69M 0.07% 310
2013
Q4 		$147M Buy
2,119,975
+257,736
+14% +$16.9M 0.06% 344
2013
Q3 		$121M Buy
1,862,239
+755,521
+68% +$47.8M 0.06% 368
2013
Q2 		$64.4M Buy
+1,106,718
New +$63.2M 0.03% 544

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.28B AUM 27.63% 1-Year Est. Return

Morgan Stanley's FBT Position: Q1 2026 in Review

Morgan Stanley increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 33% in Q1 2026, buying an estimated $27.5M and bringing the position to 534,200 shares worth $107M. The position accounts for 0.01% of the portfolio, ranked #1380.

Morgan Stanley first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $330M in Q2 2015. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Morgan Stanley held 534,200 shares of First Trust NYSE Arca Biotechnology Index Fund worth $107M as of Q1 2026.
  • Morgan Stanley bought 132,999 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $27.5M.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Morgan Stanley's portfolio in Q1 2026, its #1380 holding.
  • Morgan Stanley first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
  • Morgan Stanley's First Trust NYSE Arca Biotechnology Index Fund position peaked at $330M in Q2 2015.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.